About IBC

About the Meeting

The Intercepting Blood Cancers (IBC) 2026 workshop will provide a unique, interactive platform for presentations on key clinical trial data and expert clinical insights for early interventions in blood cancers and how this impacts outcomes for patients; three key topic tracks will include:

Monoclonal B lymphocytosis (MBL), chronic lymphocytic leukemia (CLL) and low-grade lymphoma
Myelodysplastic syndromes (MDS), clonal hematopoiesis of indeterminate potential (CHIP) and acute myeloid leukemia (AML)
Multiple myeloma (MM), smoldering multiple myeloma (SMM) and monoclonal gammopathy of undetermined significance (MGUS)

2026 Workshop

19-21 Mar

Barcelona, Spain

Workshop Objectives

The current aims of the meeting are to:

Describe current knowledge of blood cancer precursors and how these might enable early clinical intervention
Discuss ongoing clinical studies and any available data from these on treatment interceptions for early-stage blood cancers
Share knowledge and clinical insights between blood cancer disciplines and therapy areas
Plan for publication and dissemination of consensus findings from discussions across each of the key topic tracks

Meeting Organizer

Meeting Organizer

Magdalen Medical Publishing (MMP) is an agile and fast-growing digital publisher of independent, open-access medical news and education for the online healthcare professional community via their online video journals.

In addition to online publishing, MMP also develops and organizes high-level scientific meetings and workshops that promote scientific exchange such as this meeting, by bringing together leading international clinical and translational research minds.

For more information, please visit www.medicalpublishing.co.uk

Media Partner

Media Partner

The Video Journal of Hematology and Hematological Oncology (VJHemOnc) is an global, open-access video journal, dedicated to providing trusted and up-to-date independent medical education to improve the awareness of advances in the management of hematological cancers and share best practice within the hematology community.

The goal of the journal is to expedite learning through the sharing of new data and expert opinion, and to rapidly disseminate the latest news and information to healthcare professionals worldwide, in a range of innovative digital media – including video and blog formats.

VJHemOnc content is led by editorial boards of highly-respected thought leaders with a combined expertise that spans the spectrum of hematology and hematological cancers. All content is created and published under the guidance of this board of world-leading experts.

For more information, please visit www.VJHemOnc.com

2025 Agenda

Click to view the 2025 agenda developed by the Scientific Committee

Supporter Opportunities

If you are interested in becoming a supporter of IBC 2026, please contact us

IBC is an invitation-only workshop for HCPs. There are no registration fees for participants and a registration link and accommodation details are sent directly to invited HCP participants.